EMB and breast cancer: Moreover, publically available microarray data shows that embigin expression is low in breast basal-like tumors, and low embigin expression is significantly associated with decreased survival rate in patients with basal-like, the most aggressive subtype of human breast cancer, underscoring the connection between embigin loss and breast cancer progression.